UC study finds HCV-positive livers safe for transplantation; hepatitis C can be cured afterward
June 22, 2020
As part of the clinical trial at the University of Cincinnati, 32 patients received HCV-positive livers while a control group of 32 patients received non infected livers for transplantation between June 2018 and October 2019. No HCV treatment failures were reported and there were no differences in 30-day and one-year graft (or organ) and patient survival, length of hospital stay, complications or blood infections between the two groups.